VR is pharma’s next compelling digital disrupter for engagement, education, and promotion.

MM&M in partnership with PIXACORE, a leader in virtual reality technology, has created a helpful resource that will explain how VR is impacting the world of healthcare. Read eBook Now >>

CONVENTION: DISEASE EDUCATION

EPIDEMIOLOGY, CHARACTERISTICS, AND DEFINITION OF RESPONSE IN LUNG CANCER

Attendees of a cancer conference were immersed in learning about lung cancer. More than 98% of viewers experienced the entire 3-minute experience!

CONVENTION: BRAND WALKTHROUGH

MOD, MOA, EFFICACY, AND SAFETY WALKTHROUGH OF AN ONCOLOGY DRUG

HCPs were taken on a 360-degree, 3D journey of key disease state and branded information. The total experience was well received by the attendees and far exceeded total engagement and time-in-experience estimates made pre-event.

CONVENTION: ONCOLOGY PIPELINE

ANIMATED, VOICEOVER-SUPPORTED, 3D EXPLORATION OF INVESTIGATIONAL PATHWAYS

Oncologists, researchers, marketers, and other HCPs were standing in lines to experience a full 3D exploration of signaling pathways and investigational compounds. Unprecedented metrics: 3 days, 600 participants, 80 hours of engagement!

VR IN
THE
FIELD

SALES PROFESSIONALS ENGAGE HCPS IN THE FIELD WITH VIRTUAL REALITY

Oncology sales force of 100+ is using Samsung Gear VR technology to educate customers with immersive disease education.

PIXACORE’S
Scroll to explore

Cinematic Virtual Reality